An analysis by the Centers for Disease Control and Prevention (CDC) reveals a significant reduction in RSV hospitalization rates among infants and young children during the most recent RSV season.
Health experts attribute this decline to the introduction of new vaccines and antibody treatments that provide protection to the youngest and most vulnerable children.
“But we have seen a drastic decrease in hospitalizations and ICU stays, which is usually when kids get the increased work of breathing and need oxygen and support.” – Kelsey Grimes, pediatrician at OSF HealthCare
The CDC report indicates that hospitalizations among infants have decreased by 28% to 43% compared to pre-pandemic RSV seasons.
RSV remains one of the top causes of hospital admissions in infants and young children in the U.S., often causing severe respiratory illnesses, particularly in those with existing health conditions.
“These preventative options don’t stop RSV completely,” said Kelsey Grimes.
Summary: New vaccines and antibody treatments have significantly reduced RSV hospitalizations in infants, offering crucial protection as Central Illinois enters the respiratory virus season.